A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
about
Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directionsPharmacotherapy and psychotherapy for body dysmorphic disorderThe pathophysiology of body dysmorphic disorderOlfactory reference syndrome: demographic and clinical features of imagined body odorBody dysmorphic disorderBody dysmorphic disorder in an adolescent girlComorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterizationDelusionality and response to open-label fluvoxamine in body dysmorphic disorderCan understanding the neurobiology of body dysmorphic disorder (BDD) inform treatment?Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implicationsSomatization disorder: a practical review.A prospective pilot study of levetiracetam for body dysmorphic disorder.Functional impairment in body dysmorphic disorder: a prospective, follow-up study.Psychosocial functioning and quality of life in body dysmorphic disorderAge at onset and clinical correlates in body dysmorphic disorderA review of body dysmorphic disorder and its presentation in different clinical settings.Body dysmorphic disorder: recognizing and treating imagined ugliness.Psychopharmacotherapy of somatic symptoms disorders.Am I normal? A systematic review and construction of nomograms for flaccid and erect penis length and circumference in up to 15,521 men.The treatment of patients with medically unexplained symptoms in primary care: a review of the literatureObsessive-compulsive spectrum disorders: a review of the evidence-based treatments.The obsessive-compulsive spectrums.Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study.Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.Insight in obsessive compulsive disorder and body dysmorphic disorderAxis I comorbidity in body dysmorphic disorderA retrospective follow-up study of body dysmorphic disorder.Obsessive-compulsive spectrum of disorders: a defensible construct?An open-label study of escitalopram in body dysmorphic disorder.A 12-month follow-up study of the course of body dysmorphic disorder.Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.Is anorexia nervosa a subtype of body dysmorphic disorder? Probably not, but read on..."My Face Is My Fate": biological and psychosocial approaches to the treatment of a woman with obsessions and delusions.Social anxiety in body dysmorphic disorder.Recognizing and treating body dysmorphic disorder.Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.Body dysmorphic disorder and cosmetic dermatology: more than skin deepSexual Functioning and Behavior of Men with Body Dysmorphic Disorder Concerning Penis Size Compared with Men Anxious about Penis Size and with Controls: A Cohort Study.
P2860
Q22252300-B06FB2DE-4B91-483E-913C-4B5CC3DBB005Q24241607-E813B719-F03B-4080-BFF5-960C2CB788E3Q24596812-9A0123C5-FD55-41C5-AB43-49DD4FF4C974Q24632025-1D42FBF4-6220-42F4-BAF1-91D1E019DA14Q24635488-77A19390-0019-4696-80A3-699EC1221A08Q24672906-113E2034-B401-4872-8C25-84D045C50C73Q24810652-E62201AC-1886-48FF-9C01-3279E297A4DBQ26783387-A8E2858B-8D40-4C6C-BD11-6BFEC5EC7BE1Q28360056-18A43A4D-4357-4725-9DDF-DECBEBE545A1Q30977757-1397E9B1-CAFD-41BF-A395-7A36DCE53EBEQ33602052-47D4F1E1-B0EB-4CFC-897B-48687767ACD1Q33872639-BB7EEF56-7280-4951-98E3-786610FBE10EQ33983285-9FEC6ECE-6CD1-4ABF-A272-5D882312DFD7Q34139512-22533F92-42E5-4F74-A2DF-7D007D19995BQ34235161-8ACC31AF-CD98-4D47-A54F-95EEB29F2BC0Q34313825-E7E30B9A-8B0D-440F-B0EC-AAA5317BA37CQ34342844-0BCAB024-2A7F-4184-8DC5-3A1B41A34034Q34395920-BF68CC6B-71DC-40D8-8F4B-43775923DFF4Q34481772-D264B046-F37B-4679-8D35-44109149655DQ34647954-41E7F9D6-FC3A-47B3-B3E9-82979C59B76FQ34666917-EE03104B-D8E7-4F8E-AE99-7C06CB6F1750Q34870128-D3F955E2-4E53-43CA-B92C-63866615A116Q34984955-92F7200E-E8DA-4A05-AFE5-0643B82F53C5Q35014965-F14506C2-29F6-417F-85C5-E698323455E4Q35095094-796B2FB5-E316-43C6-ADFE-B3977D5C5CCFQ35095099-83071DFE-5EB7-483F-B3C3-AC371798276FQ35095139-4C10D57F-1CCE-4FB5-9B86-3E4C7A782D08Q35095150-62734971-D6F8-4EE5-B9AE-38745F288CB3Q35095156-8CCC60D0-5C74-4B4E-9C6C-9089F7E8EE07Q35095197-ED615D49-3AA7-46CB-8094-BEFCC0215BDAQ35095202-C84C4438-A351-4604-9199-2A00B2035C3FQ35095213-DB780061-BA31-4E82-9F53-FC83E8DA4226Q35108437-8631F38F-B991-4EEF-9878-2D828CE429D5Q35108442-E2D05658-2B3A-4C16-8985-A48E30833218Q35108445-9FC2D0C7-8945-40DD-BCD6-FF4F602F8AD7Q35116849-716C3936-C536-45E2-826C-AB9E1101345EQ35182122-12070A28-AEFE-4A19-9F5A-F2756B6BF6A3Q35568961-EF880F10-11D0-42A9-BC24-73F53493B314Q35616853-AE03428F-2CBE-4E6B-8369-0CFC9834246FQ36142078-EF1E870A-BB21-49FE-8B37-77DE3503C942
P2860
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@ast
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@en
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@nl
type
label
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@ast
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@en
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@nl
prefLabel
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@ast
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@en
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@nl
P2093
P1433
P1476
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
@en
P2093
Katharine A Phillips
Ralph S Albertini
Steven A Rasmussen
P304
P356
10.1001/ARCHPSYC.59.4.381
P407
P577
2002-04-01T00:00:00Z